Value8 acquires 14% stake in Fornix Biosciences - MarketLine Financial Deals

Value8 acquires 14% stake in Fornix Biosciences

Value8 acquires 14% stake in Fornix Biosciences - MarketLine Financial Deals
Value8 acquires 14% stake in Fornix Biosciences
Published Sep 22, 2010
1 pages — Published Sep 22, 2010
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Value8 N.V., an investment company, has acquired a 14% stake in Fornix Biosciences NV, a developer of diagnostic and therapeutic allergen products.

  
Source:
Document ID
MA33120_100924
Country
Ticker
VALUE=NL
Ticker
FORBI=NL
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Value8 acquires 14% stake in Fornix Biosciences" Sep 22, 2010. Alacra Store. Dec 04, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Value8-acquires-14-stake-in-Fornix-Biosciences-2052-44000>
  
APA:
MarketLine Financial Deals. (2010). Value8 acquires 14% stake in Fornix Biosciences Sep 22, 2010. New York, NY: Alacra Store. Retrieved Dec 04, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Value8-acquires-14-stake-in-Fornix-Biosciences-2052-44000>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.